Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 8, 1997 - Issue 2
Submit an article Journal homepage
27
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Comparative multicentre double-blind study of terbinafine (250 mg per day) versus griseofulvin (1 g per day) in the treatment of dermatophyte onychomycosis

R. Baran Nail Disease Center, 06400, Cannes
,
S Belaich Hopital Bichat, Paris
,
C Beylot Hopital Haut-Lévěque, Pessac
,
Jm Bonnetblanc Hopital Dupuytreu, Limoges
,
B Cribier Hopital Pasteur, Strasbourg
,
F Daniel St Joseph, Paris
,
L Dubertret Hopital Saint-Louis, Paris
,
Jp Escande Hopital Tarnier, Paris
,
B Kalis Hopital Robert Debré, Reims
,
J Meynadier Hopital Saint Charles, Montpellier
,
Y Privat Hopital Nord, Marseille
,
Y de Prost Hopital Neclser, Paris
,
J Revuz Hopital Henri Mondor, Creteil
,
B Schubert Hopital de Mulhouse
,
P Souteyrand Hopital Hotel Dieu Clermont-Ferrand
&
M Zagula Laboratoires Sandoz, 92500 Rueil MalmaisonFrance
 show all
Pages 93-97 | Received 24 Apr 1996, Accepted 19 Dec 1996, Published online: 12 Jul 2009

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Maria L. D. Fávero, Aline F. Bonetti, Eric L. Domingos, Fernanda S. Tonin & Roberto Pontarolo. (2022) Oral antifungal therapies for toenail onychomycosis: a systematic review with network meta-analysis toenail mycosis: network meta-analysis. Journal of Dermatological Treatment 33:1, pages 121-130.
Read now
Maysoon Algain. (2021) Yellow Nail Syndrome Successfully Treated with Oral Terbinafine and Topical Minoxidil. Clinical, Cosmetic and Investigational Dermatology 14, pages 249-252.
Read now
Aditya K. Gupta & Catherine Studholme. (2016) How do we measure efficacy of therapy in onychomycosis: Patient, physician, and regulatory perspectives. Journal of Dermatological Treatment 27:6, pages 498-504.
Read now

Articles from other publishers (23)

David de Berker, Beth S. Ruben & Robert Baran. 2019. Baran & Dawber's Diseases of the Nails and their Management. Baran & Dawber's Diseases of the Nails and their Management 1 58 .
Allen S. W. Oak, John W. Baddley & Boni E. Elewski. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology 425 450 .
John Montgomery Yost. 2018. Scher and Daniel's Nails. Scher and Daniel's Nails 453 489 .
Bárður Sigurgeirsson. 2018. Scher and Daniel's Nails. Scher and Daniel's Nails 185 214 .
Sanne Kreijkamp-Kaspers, Kate Hawke, Linda Guo, George Kerin, Sally EM Bell-Syer, Parker Magin, Sophie V Bell-Syer & Mieke L van Driel. (2017) Oral antifungal medication for toenail onychomycosis. Cochrane Database of Systematic Reviews 2017:7.
Crossref
Shari R. Lipner & Richard K. Scher. 2017. Agache's Measuring the Skin. Agache's Measuring the Skin 867 881 .
Bárður Sigurgeirsson. 2016. Antibiotic and Antifungal Therapies in Dermatology. Antibiotic and Antifungal Therapies in Dermatology 203 289 .
Shari R. Lipner & Richard K. Scher. 2016. Measuring the Skin. Measuring the Skin 1 15 .
David A. R. de Berker & Robert Baran. 2012. Baran & Dawber's Diseases of the Nails and their Management. Baran & Dawber's Diseases of the Nails and their Management 1 50 .
J. Thomas, G. A. Jacobson, C. K. Narkowicz, G. M. Peterson, H. Burnet & C. Sharpe. (2010) REVIEW ARTICLE: Toenail onychomycosis: an important global disease burden. Journal of Clinical Pharmacy and Therapeutics 35:5, pages 497-519.
Crossref
Chia-Hsuin Chang, Yinong Young-Xu, Tobias Kurth, John E. Orav & Arnold K. Chan. (2007) The Safety of Oral Antifungal Treatments for Superficial Dermatophytosis and Onychomycosis: A Meta-analysis. The American Journal of Medicine 120:9, pages 791-798.e3.
Crossref
Y. Scrivener. (2007) Analyse systématique des essais thérapeutiques. Annales de Dermatologie et de Vénéréologie 134:5, pages 17-45.
Crossref
Erin M. Warshaw. (2006) Evaluating Costs for Onychomycosis Treatments. Journal of the American Podiatric Medical Association 96:1, pages 38-52.
Crossref
Adam S Geyer, Neh Onumah, Hendrik Uyttendaele & Richard K Scher. (2004) Modulation of linear nail growth to treat diseases of the nail. Journal of the American Academy of Dermatology 50:2, pages 229-234.
Crossref
Aditya K. Gupta, Jennifer E. Ryder, Robyn Bluhm, Andrew Johnson & Richard C. Summerbell. (2016) Onychomycosis: Quality of Studies. Journal of Cutaneous Medicine and Surgery 7:4, pages 312-316.
Crossref
Aditya K. Gupta, Jennifer Ryder & Richard C. Summerbell. (2003) Comparison of efficacy criteria across onychomycosis trials: need for standardization. International Journal of Dermatology 42:4, pages 312-315.
Crossref
R. Baran. (2002) The new oral antifungal drugs in the treatment of the yellow nail syndrome. British Journal of Dermatology 147:1, pages 180-195.
Crossref
Aditya K. Gupta. (2002) Treatment of Dermatophyte Toenail Onychomycosis in the United States. Journal of the American Podiatric Medical Association 92:5, pages 272-286.
Crossref
Aditya K. Gupta. (2000) Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. Journal of the American Academy of Dermatology 43:4, pages S81-S95.
Crossref
Aditya K. Gupta & Neil H. Shear. (2000) A Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis. Drug Safety 22:1, pages 33-52.
Crossref
Aditya K. Gupta & Julien Lambert. (2001) Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA. International Journal of Dermatology 38:S2, pages 53-64.
Crossref
Aditya K. Gupta & Neil H. Shear. (2006) The new oral antifungal agents for onychomycosis of the toenails. Journal of the European Academy of Dermatology and Venereology 13:1, pages 1-13.
Crossref
Humphrey, Cork & Haycox. (1998) A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practice. British Journal of Dermatology 139:4, pages 660-664.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.